Intelligent Bio Solutions annual return on equity
2021
2022
2023
2024
2025
2026
Intelligent Bio Solutions Return on Equity (ROE) Growth & History (INBS)
Intelligent Bio Solutions's return on equity was −292.25% for fiscal 2026.
View full Intelligent Bio Solutions company overviewIntelligent Bio Solutions annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2026 | 2026-06-30 | −292.25% | −105.62 pp |
| 2025 | 2025-06-30 | −186.64% | −19.15 pp |
| 2024 | 2024-06-30 | −167.49% | +36.50 pp |
| 2023 | 2023-06-30 | −203.99% | −127.37 pp |
| 2022 | 2022-06-30 | −76.61% | +65.97 pp |
| 2021 | 2021-06-30 | −142.58% | — |
Intelligent Bio Solutions quarterly return on equity
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
Q3.26
Q4.26
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q4 2026 | 2026-06-30 | −54.00% | +22.21 pp |
| Q3 2026 | 2026-03-31 | −28.55% | +25.11 pp |
| Q2 2026 | 2025-12-31 | −36.39% | +6.57 pp |
| Q1 2026 | 2025-09-30 | −90.16% | −52.94 pp |
| Q4 2025 | 2025-06-30 | −76.21% | −47.60 pp |
| Q3 2025 | 2025-03-31 | −53.66% | −12.34 pp |
| Q2 2025 | 2024-12-31 | −42.97% | +42.01 pp |
| Q1 2025 | 2024-09-30 | −37.21% | +56.88 pp |
| Q4 2024 | 2024-06-30 | −28.61% | +25.51 pp |
| Q3 2024 | 2024-03-31 | −41.32% | +36.14 pp |
| Q2 2024 | 2023-12-31 | −84.97% | −79.59 pp |
| Q1 2024 | 2023-09-30 | −94.10% | −73.80 pp |
| Q4 2023 | 2023-06-30 | −54.12% | −27.13 pp |
| Q3 2023 | 2023-03-31 | −77.46% | −63.31 pp |
| Q2 2023 | 2022-12-31 | −5.38% | +23.86 pp |
| Q1 2023 | 2022-09-30 | −20.30% | −10.28 pp |
| Q4 2022 | 2022-06-30 | −26.99% | −21.49 pp |
| Q3 2022 | 2022-03-31 | −14.15% | +3.86 pp |
| Q2 2022 | 2021-12-31 | −29.24% | −0.14 pp |
| Q1 2022 | 2021-09-30 | −10.01% | — |
| Q4 2021 | 2021-06-30 | −5.51% | — |
| Q3 2021 | 2021-03-31 | −18.00% | — |
| Q2 2021 | 2020-12-31 | −29.10% | — |
Intelligent Bio Solutions return on equity trends
Over the last five fiscal years, Intelligent Bio Solutions's return on equity decreased from −142.58% to −292.25%, a change of −149.67 percentage points. The latest reported quarter, Q4 2026, shows −54.00%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Intelligent Bio Solutions source filings ↗